Ignite Creation Date:
2025-12-25 @ 3:03 AM
Ignite Modification Date:
2025-12-31 @ 3:26 PM
Study NCT ID:
NCT07033533
Status:
COMPLETED
Last Update Posted:
2025-06-24
First Post:
2025-06-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Allopurinol and Pathogenesis of Cirrhosis
Sponsor:
Tanta University
Organization:
Study Overview
Official Title:
Allopurinol Interferes With the Pathological Mechanisms of Hepatic Decompensation
Status:
COMPLETED
Status Verified Date:
2025-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Hepatic decompensation is a common healthcare issue
. This study was conducted to investigate how allopurinol can interfere with the pathological mechanisms of HD.
. This study was conducted to investigate how allopurinol can interfere with the pathological mechanisms of HD.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: